Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru mid 2025, so you can switch back as our improvements continue.
Legislation Quick Search
12/03/2024 03:34 AM
Pennsylvania General Assembly
https://www.legis.state.pa.us/cfdocs/billInfo/billInfo.cfm?sYear=2019&sInd=0&body=S&type=B&bn=675
Share:
Home / Bill and Amendments / Bill Information

Bill Information

Regular Session 2019-2020
Senate Bill 675


Short Title:
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Prime Sponsor:
Last Action:
Referred to HUMAN SERVICES, June 18, 2019 [House]
Printer's No.:
Printer's No. Text (H) Amendments (S) Amendments (H) Fiscal Note (S) Fiscal Note Actuarial Note
820*
* denotes current Printer's Number